Last Updated On 5/6/2022 5:18:39 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
Company: Medscape |
Recipient: You |
Company: Foundation Medicine |
Recipient: You |
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
Company: Foundation Medicine |
Recipient: You |
|
Consulting or Advisory Role |
Company: Boehringer Ingelheim |
Recipient: You |
Company: Shire |
Recipient: You |
Company: Exelixis |
Recipient: You |
Company: QED Therapeutics |
Recipient: You |
Company: HalioDx |
Recipient: You |
Company: Natera |
Recipient: You |
Company: Ipsen |
Recipient: You |
Company: Novartis |
Recipient: You |
|
Speakers' Bureau |
Company: AstraZeneca/Daiichi Sankyo |
Recipient: You |
|
Research Funding |
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
Company: Medscape |
Recipient: You |
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|